B16.1
Acute hepatitis B with delta-agent without hepatic coma
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute hepatitis B with delta-agent, classified under ICD-10 code B16.1, is a liver infection caused by the hepatitis B virus, accompanied by co-infection with the delta-agent (hepatitis delta virus). This condition reflects an active infection where both viruses infect the liver simultaneously, potentially leading to more severe liver inflammation. Despite the absence of hepatic coma, it requires medical attention to manage symptoms and prevent complications.
Causes & Symptoms
Clinical Causes: Transmission of hepatitis B virus through contact with infected blood or bodily fluids. Co-infection with hepatitis delta virus (HDV), which requires the hepatitis B virus for replication. Sharing contaminated needles or syringes. Unprotected sexual contact with an infected person. From mother to child during childbirth in areas with high hepatitis B prevalence. Exposure to contaminated blood products or medical equipment.
Key Symptoms: Fatigue and weakness Loss of appetite Nausea and vomiting Abdominal pain or discomfort, especially in the upper right side Low-grade fever Dark urine Pale-colored stool Jaundice (yellowing of the skin and eyes) Muscle or joint pain
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to detect hepatitis B surface antigen (HBsAg) and hepatitis delta antibodies, confirming active infection. Liver function tests are used to assess the extent of liver inflammation. Additional tests may include imaging studies like ultrasound to evaluate liver health and exclude other causes of liver disease. Distinguishing between different forms of hepatitis B and delta co-infection helps guide treatment plans.
Treatment Protocols: While many cases of acute hepatitis B resolve on their own, management focuses on supportive care to reduce symptoms and prevent complications. This includes resting, maintaining hydration, and avoiding alcohol or hepatotoxic medications. In cases with significant liver inflammation or risk factors, medical professionals may consider antiviral therapies. Monitoring liver function and overall health is vital during recovery. Vaccination against hepatitis B and measures to prevent transmission are crucial for long-term health.
Clinical Advice & FAQs
Billing Guidance
Is B16.1 a billable ICD-10 code?
Yes, B16.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B16.1?
Clinical documentation must specify the nature of Acute hepatitis B with delta-agent without hepatic coma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference